NiftyPulse360
NiftyPulse360Market Intelligence
Bank Nifty 55,293.65 ▲2.29%Sensex 76,488.96 ▲1.42%Nifty 50 24,031.7 ▲1.32%GOLD 24K ₹13962/g ▼0.76%SILVER ₹238/g ▲5397186133.11%BRENT CRUDE $110.10 ▼1.78%ADANIPORTS ₹1805 ▲1.01%TECHM ₹1439 ▲1.15%DIVISLAB ₹6791 ▼1.39%ULTRACEMCO ₹11733 ▲1.42%WIPRO ₹206 ▲1.42%MARUTI ₹13188 ▲1.55%Bank Nifty 55,293.65 ▲2.29%Sensex 76,488.96 ▲1.42%Nifty 50 24,031.7 ▲1.32%GOLD 24K ₹13962/g ▼0.76%SILVER ₹238/g ▲5397186133.11%BRENT CRUDE $110.10 ▼1.78%ADANIPORTS ₹1805 ▲1.01%TECHM ₹1439 ▲1.15%DIVISLAB ₹6791 ▼1.39%ULTRACEMCO ₹11733 ▲1.42%WIPRO ₹206 ▲1.42%MARUTI ₹13188 ▲1.55%

Why Did Dr Reddy's Laboratories Ltd (DRREDDY) Share Price Rise 1.97% Today?

By Market Data DeskPublished 25 May 2026, 12:32 PM ISTNSEPharma
📊 Sources:NSE/BSE official dataReuters, PTI, ET, Moneycontrol, company filingsOur methodology →

Price Performance Summary

Dr Reddy's Laboratories Ltd
DRREDDYNSEPharma
1333.00
26.26 (+1.97%)
Open
1320.00
High
1340.50
Low
1298.70
Prev Close
1306.74
Volume: 28.80Lvs Avg: 1.0x52W High: 138052W Low: 114852W Range: 80%

Key Reasons for Today's Rise

Dr Reddy's Laboratories Ltd (DRREDDY) shares rose 1.97% on 25 May 2026, closing at ₹1333.00. Today's news shows: Oracle, Wipro, Tech Mahindra stocks fuel the Nifty IT index above 29,000. Volume today was 28.8L shares, 1.0x the 30-day average — reflecting moderate participation. Sector performance data unavailable, with the stock outperforming its sector. The 52-week range stands at ₹1148 to ₹1380. Investors should monitor follow-up volume and any further news in coming sessions to confirm the trend.

What the Volume Tells Us

Trading volume today was 28.80 L shares, 1.0x the 30-day average of 28.80 L. This is in line with normal trading activity, suggesting the move is driven more by retail flows than institutional repositioning.

Sector & Market Context

Dr Reddy's Laboratories Ltd operates in the Pharma sector. The Nifty 50 gained 1.32% today. DRREDDY outperformed the broader market by 0.65 percentage points. Tracking sector peers and the broader index helps determine whether the move is company-specific or part of a wider trend.

52-Week Range & Technical Context

Dr Reddy's Laboratories Ltd has traded between ₹1148.40 (52-week low) and ₹1379.70 (52-week high) over the past year. At the current price of ₹1333.00, the stock is at 80% of its 52-week range. The stock is trading near its yearly highs, suggesting strong momentum.

Latest News on Dr Reddy's Laboratories Ltd

Showing news from last 48 hours

Frequently Asked Questions About Dr Reddy's Laboratories Ltd

Why did Dr Reddy's Laboratories Ltd share price rise today?

Dr Reddy's Laboratories Ltd (DRREDDY) rose 1.97% on 25 May 2026 due to Oracle, Wipro, Tech Mahindra stocks fuel the Nifty IT index above 29,000. Trading volume was 28.8L shares.

What is Dr Reddy's Laboratories Ltd's 52-week high and low?

Dr Reddy's Laboratories Ltd's 52-week high is ₹1379.70 and 52-week low is ₹1148.40. The current price of ₹1333.00 is 80% of this range.

Is Dr Reddy's Laboratories Ltd a good stock to watch after today's move?

Today's 2.0% rise in DRREDDY on 28.8L volume is worth tracking. Investors should monitor follow-through price action and upcoming corporate announcements. This is not financial advice — please consult a SEBI-registered advisor before investing.

Disclaimer: NiftyPulse360 is not a SEBI-registered investment advisor. The information above is for educational purposes only and should not be construed as financial advice. Always consult a qualified advisor before making investment decisions.

💼 Expert View

Analyst ratings and broker views for Dr Reddy's Laboratories Ltdare tracked across major brokerages including Motilal Oswal, ICICI Securities, and HDFC Securities. Investors should consider the consensus target price, upcoming earnings calendar, and any analyst upgrade/downgrade actions when evaluating today's rally. Compare with sector peers DIVISLAB for relative strength analysis.

Note: NiftyPulse360 does not provide buy/sell recommendations. Consult a SEBI-registered investment advisor before making decisions.

Pharma Sector Peers